EZH2 and cancer: Despite its increased activity on H3K27me1 (with little gain in activity for H3K27me2), the observation that EZH2 A687V can drive conversion of H3K27me2 to H3K27me3 is in line with previous reports that have both predicted [17] and demonstrated this ability in cancer cell lines [18].